Improving quality control for CAR T cell therapies
Drug Discovery World
AUGUST 10, 2022
And now, with more than 600 CAR T trials recruiting or ongoing, these cells represent a majority of the cellular immunotherapies in development today. Unlike qPCR, which requires users to generate a standard curve to estimate the concentration of DNA or RNA in a sample, ddPCR technology quantifies nucleic acids directly.
246 
Let's personalize your content